CONMED Corporation (CNMD) is a publicly traded Healthcare sector company. As of May 21, 2026, CNMD trades at $36.68 with a market cap of $1.10B and a P/E ratio of 24.16. CNMD moved +1.96% today. Year to date, CNMD is -11.63%; over the trailing twelve months it is -38.15%. Its 52-week range spans $33.21 to $78.00. Analyst consensus is neutral with an average price target of $39.24. Rallies surfaces CNMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading CNMD stock inside the company?
Recent CNMD insider activity includes Glaze Richard sold 257, Garner Todd W sold 3.50K, Farkas Charles sold 1.10K, Farkas Charles sold 897, and Garner Todd W sold 598. Rallies tracks insider transaction dates, shares, prices, and estimated values.
CNMD Key Metrics
Key financial metrics for CNMD
Metric
Value
Price
$36.68
Market Cap
$1.10B
P/E Ratio
24.16
EPS
$1.52
Dividend Yield
0.20%
52-Week High
$78.00
52-Week Low
$33.21
Volume
70
Avg Volume
0
Revenue (TTM)
$1.37B
Net Income
$47.05M
Gross Margin
54.59%
Recent CNMD Insider Trades
Glaze Richard sold 257 (~$10.59K) on Nov 21, 2025.
Garner Todd W sold 3.50K (~$150.50K) on Nov 6, 2025.
Farkas Charles sold 1.10K (~$59.05K) on Sep 12, 2025.
Farkas Charles sold 897 (~$48.00K) on Sep 12, 2025.
Recent CNMD insider activity includes Glaze Richard sold 257, Garner Todd W sold 3.50K, Farkas Charles sold 1.10K, Farkas Charles sold 897, and Garner Todd W sold 598. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for CNMD?
Yes. Rallies tracks CNMD insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is CNMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CNMD. It does not provide personalized investment advice.
